Format

Send to

Choose Destination
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M1-M19. doi: 10.1167/iovs.18-25980.

IMI - Myopia Control Reports Overview and Introduction.

Author information

1
Ophthalmic Research Group, Aston University, Birmingham, United Kingdom.
2
Children's University Hospital, University College Dublin and Dublin Institute of Technology, Dublin, Ireland.
3
Private Practice and Queensland University of Technology, Queensland, Australia.
4
Brien Holden Vision Institute and School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.
5
Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, Waterloo, Canada.
6
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
7
African Vision Research Institute, University of KwaZulu-Natal, Durban, South Africa.
8
College of Optometry, University of Houston, Houston, Texas, United States.
9
SUNY College of Optometry, State University of New York, New York, New York, United States.
10
Berkeley Myopia Research Group, School of Optometry & Vision Science Program, University of California Berkeley, Berkeley, California, United States.

Abstract

With the growing prevalence of myopia, already at epidemic levels in some countries, there is an urgent need for new management approaches. However, with the increasing number of research publications on the topic of myopia control, there is also a clear necessity for agreement and guidance on key issues, including on how myopia should be defined and how interventions, validated by well-conducted clinical trials, should be appropriately and ethically applied. The International Myopia Institute (IMI) reports the critical review and synthesis of the research evidence to date, from animal models, genetics, clinical studies, and randomized controlled trials, by more than 85 multidisciplinary experts in the field, as the basis for the recommendations contained therein. As background to the need for myopia control, the risk factors for myopia onset and progression are reviewed. The seven generated reports are summarized: (1) Defining and Classifying Myopia, (2) Experimental Models of Emmetropization and Myopia, (3) Myopia Genetics, (4) Interventions for Myopia Onset and Progression, (5) Clinical Myopia Control Trials and Instrumentation, (6) Industry Guidelines and Ethical Considerations for Myopia Control, and (7) Clinical Myopia Management Guidelines.

PMID:
30817825
PMCID:
PMC6735780
DOI:
10.1167/iovs.18-25980
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center